Increase in percent free prostate-specific antigen in men with chronic kidney disease
- 4 December 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (4) , 1238-1241
Abstract
Prostate-specific antigen (PSA) occurs in different molecular forms in serum: free PSA (fPSA) and complexed PSA (cPSA), the sum of which corresponds to total PSA (tPSA). In addition to tPSA, percent fPSA is widely used in the detection of prostate cancer. Free PSA, approximately 28 kDa, is eliminated by glomerular filtration. Previous data showed that men with end-stage renal dysfunction requiring chronic dialysis have increased percent fPSA. In this study, we evaluated whether moderate-to-severe chronic renal dysfunction, but with no need for dialysis, also importantly affects percent fPSA. The study group consisted of 101 men (median age 57 years, interquartile range 46-68) with chronic kidney disease and no diagnosis of prostate cancer. Their median glomerular filtration rate (GFR) was 23 mL/min/1.73 m(2) (interquartile range 16-33; range 8-83), determined by iohexol clearance. Controls included 5264 men (median age 57 years, interquartile range 54-62) attending a prostate cancer screening program with no diagnosis of prostate cancer during 8 years of follow-up. With adjustment for age, median fPSA levels and percent fPSA were significantly higher (P < 0.001) in patients with renal dysfunction, 0.45 microg/L and 47.2%, respectively, compared to controls, 0.29 microg/L and 29.9%, respectively. Regression analysis in the study group showed a significant association between GFR and percent fPSA (P = 0.036). The percent fPSA is importantly influenced by moderately impaired renal function in men with chronic kidney disease. For such men, use of the current clinical decision limits for percent fPSA could cause some men with prostate cancer to be misdiagnosed as having benign disease, and therefore fPSA should not be used to diagnose prostate cancer in these patients.Keywords
This publication has 30 references indexed in Scilit:
- Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at −20 °CClinical Chemistry, 2006
- Use of Prostate-Specific Antigen (PSA) Isoforms for the Detection of Prostate Cancer in Men with a PSA Level of 2–10 ng/ml: Systematic Review and Meta-AnalysisEuropean Urology, 2005
- Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomyClinica Chimica Acta, 2005
- RAPID ELIMINATION BY GLOMERULAR FILTRATION OF FREE PROSTATE SPECIFIC ANTIGEN AND HUMAN KALLIKREIN 2 AFTER RENAL TRANSPLANTATIONJournal of Urology, 2004
- Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinomaCancer, 2004
- cPSA and fPSA elimination in African-American menProstate Cancer and Prostatic Diseases, 2003
- SERUM LEVELS OF TOTAL AND FREE PROSTATE SPECIFIC ANTIGEN IN MEN ON HEMODIALYSISJournal of Urology, 1998
- Effect of Terminal Renal Failure on the Ratio of Free to Total Prostate-Specific AntigenTumor Biology, 1998
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- A Simple Method for the Determination of Glomerular Filtration RateScandinavian Journal of Clinical and Laboratory Investigation, 1972